High drug loading system to co-deliver anticancer drugs and nucleic acids for cancer therapy
US9878049B2 · kind B2 · utility
1Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2014 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Mar 3, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/645
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A high drug loading system is described comprising of at least one anticancer drug; at least one peptide; and at least one nucleic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.